BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35968603)

  • 1. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
    Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
    World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO31 sensitizes cancer stem cells-like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma.
    Zhu Z; Zheng Y; He H; Yang L; Yang J; Li M; Dai W; Huang H
    Liver Int; 2022 Dec; 42(12):2871-2888. PubMed ID: 36269678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.
    Wen LJ; Yin JG; Wang YX; Liu K; Zhao JX
    Parasit Vectors; 2023 Dec; 16(1):465. PubMed ID: 38124152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells.
    Li S; Wang M; Wang Y; Guo Y; Tao X; Wang X; Cao Y; Tian S; Li Q
    Toxicol In Vitro; 2021 Jun; 73():105146. PubMed ID: 33737050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3/p53/SLC7A11 signaling pathway.
    Li X; Qi H; Zhang X; Liang H; Zeng N
    J Ethnopharmacol; 2023 Nov; 316():116689. PubMed ID: 37315642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells.
    Luo Y; Gao X; Zou L; Lei M; Feng J; Hu Z
    Oxid Med Cell Longev; 2021; 2021():1783485. PubMed ID: 34707773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
    Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
    Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head.
    Sun F; Zhou JL; Liu ZL; Jiang ZW; Peng H
    Biochem Biophys Res Commun; 2022 Apr; 602():149-155. PubMed ID: 35276555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
    Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
    Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro.
    Li Q; Peng F; Yan X; Chen Y; Zhou J; Wu S; Jiang W; Jin X; Liang J; Peng C; Pan X
    J Ethnopharmacol; 2023 Mar; 303():116029. PubMed ID: 36503029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Significance of Ferroptosis-related Proteins SLC7A11 and GPX4 in Renal Cell Carcinoma.
    Ren Z; Zhang X; Han J
    Protein Pept Lett; 2023; 30(10):868-876. PubMed ID: 37807410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM46 contributes to high glucose-induced ferroptosis and cell growth inhibition in human retinal capillary endothelial cells by facilitating GPX4 ubiquitination.
    Zhang J; Qiu Q; Wang H; Chen C; Luo D
    Exp Cell Res; 2021 Oct; 407(2):112800. PubMed ID: 34487731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galangin attenuated cerebral ischemia-reperfusion injury by inhibition of ferroptosis through activating the SLC7A11/GPX4 axis in gerbils.
    Guan X; Li Z; Zhu S; Cheng M; Ju Y; Ren L; Yang G; Min D
    Life Sci; 2021 Jan; 264():118660. PubMed ID: 33127512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 19. Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway.
    Zou W; Wang X; Xia X; Zhang T; Nie M; Xiong J; Fang X
    Biochem Biophys Res Commun; 2024 Jan; 692():149338. PubMed ID: 38043156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway.
    Jin X; He R; Lin Y; Liu J; Wang Y; Li Z; Liao Y; Yang S
    Drug Des Devel Ther; 2023; 17():3363-3383. PubMed ID: 38024532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.